Log in to your Inderes Free account to see all free content on this page.

Abera Bioscience

6.82 SEK

+3.02%

Less than 1K followers

ABERA

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

+3.02 %
+13.67 %
+17.59 %
+0.29 %
+8.25 %
-19.76 %
+33.73 %
-45.44 %
-38.28 %

Abera Bioscience is a Swedish biotechnology company that develops nasal vaccines based on a proprietary OMV-based platform technology. The company's focus is on nasal vaccines that provide immune responses in both mucosal and systemic areas. Abera develops vaccines against several respiratory infectious diseases, including pneumococci, influenza and pandemic preparedness, with projects in preclinical and planned clinical phases. The company was founded in 2012 and is headquartered in Uppsala.

Read more
Market cap
139.8M SEK
Turnover
82.86K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12.5.
2026

Interim report Q1'26

10.6.
2026

General meeting '26

20.8.
2026

Interim report Q2'26